Daily analysis blog

  Biosimilars Biosimilars are a class of biological products that are highly similar to, and have no clinically meaningful differences from, existing reference biologics. They are developed to be highly comparable in terms of quality, safety, and efficacy to the reference products, which are already approved and marketed. Biosimilars offer an important opportunity to increase patient access to life-saving and life-enhancing therapies while promoting competition and reducing healthcare costs. Unlike generic versions of small-molecule drugs, which are exact copies of their reference products, Biosimilars are complex molecules produced from living organisms. They are developed through a rigorous process that involves comparing the biosimilar candidate to the reference product through extensive analytical studies, non-clinical testing, and clinical trials in order to demonstrate similarity in terms of efficacy, safety, and immunogenicity. The development of Biosimilars requires a ...

  Synthetic Biology In the scientific field of " Synthetic Biology ," organisms are engineered to have new capabilities in order to undergo redesigning for practical uses. For the purpose of trying to address issues in agriculture, industry, and health, synthetic biology researchers and businesses all around the world are using the power of nature. Synthetic biology initiatives frequently aim to redesign organisms so that they can create a material, such as a drug or fuel, or acquire a new capability, such as the capacity to sense something in the environment. Examples of what researchers are creating using synthetic biology include:   Bioremediation uses microorganisms to remove toxins from our water, soil, and air. Beta-carotene, a mineral often connected with carrots, is produced by rice that has been altered in order to prevent vitamin A insufficiency. A lack of vitamin A significantly raises a child's chance of dying from infectious infections and causes blindnes...